|
Intralamellar aortic medial fibrosis
|
HP_0032090 |
[A type of aortic medial fibrosis in which the increase in collagen does not significantly alter the arrangement of the lamellar units.] |
|
right lung lobe
|
UBERON_0006518 |
[A lobe of lung that is part of a right lung.] |
|
smooth muscle fiber of descending colon
|
CL_1000284 |
[A smooth muscle cell that is part of the descending colon.] |
|
smooth muscle cell of rectum
|
CL_1000286 |
[A smooth muscle cell that is part of the rectum.] |
|
smooth muscle cell
|
CL_0000192 |
[A non-striated, elongated, spindle-shaped cell found lining the digestive tract, uterus, and blood vessels. They develop from specialized myoblasts (smooth muscle myoblast).] |
|
smooth muscle cell of sigmoid colon
|
CL_1000285 |
[A smooth muscle cell that is part of the sigmoid colon.] |
|
Perioral radial furrowing
|
HP_0032099 |
[The presence of radial grooves in the skin surrounding the mouth (see Figure 4 of PMID:27833976).] |
|
Hypomanganesemia
|
HP_0032098 |
[A reduction below the normal concentration of manganese in the blood.] |
|
Hypermanganesemia
|
HP_0032097 |
[An elevation above the normal concentration of manganese in the blood.] |
|
obsolete Increased hemoglobin concentration
|
HP_0020063 |
|
|
Abnormal total eosinophil count
|
HP_0020064 |
[Abnormal increase or decrease of absolute number of eosinophils in the blood, per microlitre, compared to a reference range for a given sex and age-group.] |
|
Diminished PMS2 expression
|
HP_0020065 |
[Immunohistochemistry (IHC) demonstrating loss of expression of the mismatch repair gene product PMS1 homolog 2 (PMS2).] |
|
Abnormal marker expression
|
HP_0020053 |
[Aberrant marker expression is a phenomenon of abnormal gain or loss of lineage specific or associated antigens. It involves changes in the presence, absence, quantity, or localization of molecular or immunohistochemical markers.] |
|
protein modification process
|
GO_0036211 |
[The covalent alteration of one or more amino acids occurring in proteins, peptides and nascent polypeptides (co-translational, post-translational modifications). Includes the modification of charged tRNAs that are destined to occur in a protein (pre-translation modification).] |
|
macromolecule modification
|
GO_0043412 |
[The covalent alteration of one or more monomeric units in a polypeptide, polynucleotide, polysaccharide, or other biological macromolecule, resulting in a change in its properties.] |
|
Pathological inclusion body by subcellular location
|
HP_0020066 |
|
|
Pathological inclusion body
|
HP_6001025 |
[Pathological inclusion bodies are are composed of glycogen, proteins, nucleic acids, lipids, hemosiderin, and calcium, that accumulate as metabolic by-products, catabolic products of macromolecular complexes, or in the context of cell injury.] |
|
Pathological inclusion body by anatomical location
|
HP_0020067 |
|
|
Appendicular location
|
HP_0020069 |
[Applies to a lesion that is localized on the arm or leg.] |
|
Facial-lingual fasciculations
|
HP_0007089 |
[Fasciculations affecting the tongue muscle and the musculature of the face.] |